Colossal
PrivateLast Round
Series C
Extension
Sep 17, 2025
Est. Valuation
$10.32B
Total Funding Raised
$545M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to developing innovative technologies aimed at advancing genomics, including species de-extinction and ecosystem restoration through the application of CRISPR technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Colossal Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Colossal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 17, 2025 | ||||
| Series C | Jan 15, 2025 | ||||
| Series B | Jan 31, 2023 | ||||
| Grant | Oct 5, 2022 | ||||
| Series A | Mar 9, 2022 | ||||
Seed | Sep 13, 2021 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER |
Key People
Founding team and executive leadership
Colossal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TWG Global | Series C |
| S32 | Series A |
| Breyer Capital | Series C, Series B, Series A, Seed |
| Global Space Ventures | Seed |
| Untamed Planet | Series A |
| US Innovative Technology Fund | Series B |
| Builders VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Partnered with Endangered Wildlife Trust for bluebuck rewilding.
- Apr 21, 2026
Won a gold Edison Award for mammalian cloning method.
Colossal Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Colossal's valuation, stock price, and market status.